The purpose of this trial is to see how safe the combination of naproxen sodium 440 mg and
diphenhydramine hydrochloride (DPH) 50 mg (the investigational product) is compared to
placebo (capsules containing no drug) when taken for 10 days.
Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine
Completed
Bayer
Phase 4
2008-01-01
The objectives of the study are to evaluate the analgesic and hypnotic efficacy of naproxen
sodium and diphenhydramine combination when compared to naproxen sodium, diphenhydramine, and
an ibuprofen and diphenhydramine combination
Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain
Completed
Bayer
Phase 3
2010-10-01
The objective of the study is to evaluate the efficacy and safety of a single oral dose of
two dose combinations of naproxen sodium and diphenhydramine (DPH) to demonstrate that
naproxen sodium/DPH combination provides added clinical benefit to sleep improvement than
either single ingredient alone in subjects with post-surgical dental pain and phase advanced
sleep.
The purpose of this trial is to see how safe the combination of naproxen sodium 440 mg and
diphenhydramine hydrochloride (DPH) 50 mg (the investigational product) is compared to
placebo (capsules containing no drug) when taken for 10 days.
Evaluate Analgesic / Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain
Completed
Bayer
Phase 3
2011-12-01
The objective of the study is to evaluate the efficacy and safety of a single oral dose of
naproxen sodium 440 mg in combination with DPH (diphenhydramine) 25 mg in subjects with
postsurgical dental pain and phase advanced sleep.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
